Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Indo US BioTech IPO.
March 14, 2024 2:33:00 PM
with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...
Published by : The Wall Street Journal on MSNMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 20, 2024 9:50:00 AM
Five IPOs raised $858m this past week, led by Ibotta & Centuri Holdings. Street research is expected for 3 companies in the week ahead, and lock-up periods will be expiring for 3 companies.
Published by : Seeking AlphaMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumApril 1, 2024 3:30:00 AM
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we learn about how scientists had a happenstance ...
Published by : STATMarch 30, 2024 9:30:00 AM
Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted ...
Published by : Seeking AlphaApril 12, 2024 2:32:00 PM
The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter ... to tap the public markets, it shows us that there's health in the private space ...
Published by : Yahoo FinanceApril 3, 2024 12:30:00 PM
The first quarter saw a hopeful glimmer in the IPO markets with a handful of companies announcing plans to take the plunge. The largest was CG Oncology, which had a total transaction value of $380 ...
Published by : FierceBiotechOctober 12, 2023 9:50:00 PM
A commonly held perception in the biotech industry is that the sector is currently going through an acute painful malaise: no initial public offerings (IPOs ... went public on US exchanges ...
Published by : NatureMarch 29, 2024 3:30:00 AM
Aardvark Therapeutics, a US biotech group developing a ... The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceMarch 21, 2024 6:34:00 PM
Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...
Published by : Benzinga.comThe IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:
The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.
The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.
The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.
The Indo US BioTech IPO is proposed to open on April 30, 2018. The IPO application ends on May 3, 2018.
Retail investors can apply in the retail or non-institutional investor category from April 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Indo US BioTech IPO will open for subscription on April 30, 2018. The public issue will close on May 3, 2018.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
